CAST Bio is a preclinical-stage biotechnology company pioneering Cancer Stromal Targeting (CAST), a differentiated approach to antibody-drug conjugate development
CAST Bio is a preclinical-stage biotechnology company pioneering Cancer Stromal Targeting (CAST), a differentiated approach to antibody-drug conjugate development. Unlike conventional ADCs that depend primarily on tumor cell-surface antigens, our approach is designed to target the tumor stroma and enable localized payload release within the tumor microenvironment.